ID23528A - Pengobatan terapeutik untuk gangguan kulit - Google Patents

Pengobatan terapeutik untuk gangguan kulit

Info

Publication number
ID23528A
ID23528A IDW991443A ID991443A ID23528A ID 23528 A ID23528 A ID 23528A ID W991443 A IDW991443 A ID W991443A ID 991443 A ID991443 A ID 991443A ID 23528 A ID23528 A ID 23528A
Authority
ID
Indonesia
Prior art keywords
therapeutic treatment
skin disorders
disorders
skin
therapeutic
Prior art date
Application number
IDW991443A
Other languages
English (en)
Inventor
Michael R Jirousek
Lawrence E Stramm
Vignati Louis
Ways Douglas Kirk
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ID23528A publication Critical patent/ID23528A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrrole Compounds (AREA)
IDW991443A 1997-04-30 1998-04-21 Pengobatan terapeutik untuk gangguan kulit ID23528A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4443197P 1997-04-30 1997-04-30

Publications (1)

Publication Number Publication Date
ID23528A true ID23528A (id) 2000-04-27

Family

ID=21932346

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW991443A ID23528A (id) 1997-04-30 1998-04-21 Pengobatan terapeutik untuk gangguan kulit

Country Status (16)

Country Link
US (1) US6093740A (id)
EP (1) EP0903145A3 (id)
JP (1) JP2002501501A (id)
KR (1) KR20010020381A (id)
CN (1) CN1259866A (id)
AU (1) AU7131898A (id)
BR (1) BR9809343A (id)
CA (1) CA2289257A1 (id)
EA (1) EA199900987A1 (id)
HU (1) HUP0002836A2 (id)
ID (1) ID23528A (id)
IL (1) IL132520A0 (id)
NO (1) NO995231L (id)
PL (1) PL336760A1 (id)
TR (1) TR199902682T2 (id)
WO (1) WO1998048795A1 (id)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2016953A3 (en) * 1998-12-22 2009-04-15 Genentech, Inc. Vascular endothelial cell growth factor antagonists and uses thereof
HU229628B1 (en) * 1999-12-22 2014-03-28 Scripps Research Inst Angiogenesis and vascular permeability modulators and inhibitors
JP3429297B1 (ja) 2002-02-20 2003-07-22 株式会社ノエビア 皮膚外用剤
US8846039B2 (en) * 2002-04-26 2014-09-30 Asan Laboratories Company (Cayman), Limited Method for ameliorating pruritus
US8163764B2 (en) * 2002-04-26 2012-04-24 Asan Laboratories Company (Cayman) Limited Skincare methods
TWI324604B (en) 2003-06-18 2010-05-11 Novartis Ag New use of staurosporine derivatives
US20070032479A1 (en) * 2003-12-03 2007-02-08 Leventer Steven M Treatment of inflammatory disorders of the epithelium with low dose 2,3-benzodiazepines
DE102004019413A1 (de) * 2004-04-19 2005-11-24 Phenos Gmbh Hemmung der Proteinkinase C epsilon zur Behandlung von Krankheiten
ATE476986T1 (de) 2006-01-18 2010-08-15 Gen Hospital Corp Verfahren zur steigerung der lymphatischen funktion
US7455447B2 (en) * 2006-05-19 2008-11-25 Mediatek Inc. Method and apparatus for a portable device
CN101380317B (zh) * 2007-09-07 2010-12-08 英属开曼群岛商安盛开发药物股份有限公司 减缓搔痒症的药学组合物
KR102042015B1 (ko) * 2011-06-13 2019-11-07 더 보오드 오브 트러스티스 오브 더 유니버시티 오브 일리노이즈 폐 손상, 천식, 과민증, 혈관 부종, 전신 혈관 투과성 증후군 및 비충혈을 치료하는 펩티드 조성물과 이들로 이러한 질환을 치료하는 방법
EP3554498A1 (en) * 2016-12-19 2019-10-23 Chromaderm, Inc. Methods of treating hyperpigmentation disorders
KR20250024938A (ko) 2022-05-20 2025-02-20 덤바이온트, 인코포레이티드 피부 질환, 병태 및 장애의 예방, 치료 및 개선을 위한 pk 억제제의 사용을 위한 조성물 및 제제

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK75289A3 (en) * 1988-02-10 1998-05-06 Hoffmann La Roche Substituted pyrroles, their use for producing a drug, and the drug on their base
EP0657411B1 (en) * 1993-12-07 1999-06-09 Eli Lilly And Company Synthesis of bisindolylmaleimides
US5624949A (en) * 1993-12-07 1997-04-29 Eli Lilly And Company Protein kinase C inhibitors
PL182124B1 (pl) * 1993-12-07 2001-11-30 Lilly Co Eli Nowe zwiazki oraz srodek farmaceutyczny przeznaczony do leczenia powiklan cukrzycowych lub do leczenia nowotworów PL PL PL PL PL PL PL PL
US5545636A (en) * 1993-12-23 1996-08-13 Eli Lilly And Company Protein kinase C inhibitors
US5481003A (en) * 1994-06-22 1996-01-02 Eli Lilly And Company Protein kinase C inhibitors
US5491242A (en) * 1994-06-22 1996-02-13 Eli Lilly And Company Protein kinase C inhibitors
CA2237221C (en) * 1995-11-20 2003-03-25 Eli Lilly And Company Protein kinase c inhibitor
UA54427C2 (uk) * 1996-05-01 2003-03-17 Елі Ліллі Енд Компані Спосіб лікування очних захворювань, які пов'язані з фактором васкулярного ендотеліального росту
BR9710706A (pt) * 1996-05-01 1999-08-17 Lilly Co Eli Tratamento terap-utico para doen-as relacionadas a vegf

Also Published As

Publication number Publication date
HUP0002836A2 (hu) 2001-02-28
JP2002501501A (ja) 2002-01-15
TR199902682T2 (xx) 2000-05-22
WO1998048795A1 (en) 1998-11-05
BR9809343A (pt) 2000-07-04
PL336760A1 (en) 2000-07-17
EP0903145A3 (en) 2001-02-07
IL132520A0 (en) 2001-03-19
NO995231D0 (no) 1999-10-26
CA2289257A1 (en) 1998-11-05
AU7131898A (en) 1998-11-24
EA199900987A1 (ru) 2000-08-28
KR20010020381A (ko) 2001-03-15
NO995231L (no) 1999-12-27
US6093740A (en) 2000-07-25
CN1259866A (zh) 2000-07-12
EP0903145A2 (en) 1999-03-24

Similar Documents

Publication Publication Date Title
DE69524138D1 (de) Hautbehandlungsmittel
EE04390B1 (et) Paikne preparaat dermatoloogiliste seisundite raviks
DE69825447D1 (de) Gerät zur dermatologischen behandlung
CY2014005I2 (el) Τοπικα συστηματα παροχης γελης για την θεραπευτικη αντιμετωπιση των διαταραχων δερματος
PT861081E (pt) Utilizacao de epinastina para o tratamento de dores
NO992806D0 (no) Terapeutiske midler
NO993393L (no) Fotokjemoterapeutiske blandinger
NO985066D0 (no) Terapeutisk behandling for VEGF-relaterte sykdommer
DE69818554D1 (de) Körperhaarbehandlungsgerät
NO20005884D0 (no) Kombinasjonsterapi for behandling av bipolare forstyrrelser
HUP0002030A3 (en) Use of glur5 receptorantagonists for the treatment of pain
IL129144A0 (en) Use of 1-hydroxy-2-pyridones for the treatment of skin diseases
NO995231D0 (no) Terapeutisk behandling av hudlidelser
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
IT1290781B1 (it) Agente attivo terapeutico per il trattamento di malattie degenerative neuronali.
FI973023L (fi) Liikakasvusairauksien yhdistetty terapeuttinen hoito
ID24060A (id) Pengolahan kulit hewan yang ditingkatkan
IL131347A0 (en) Treatment of skin disorders
PT1200447E (pt) Oxazinocarbazoles para o tratamento de doencas do snc
ID24922A (id) Terapi kombinasi untuk pengobatan aids
DE69722178D1 (de) Therapeutischer wirkstoff für augenerkrankungen
FI952953L (fi) Aineita metabolisten luustosairauksien hoitamiseen
GB0020261D0 (en) Therapeutic treatment
ID24439A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia
ID24521A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia